The sensitivity of tumor cells with high Cyclin D1 expression to selective estrogen receptor modulators has been found to be compound specific, but no effect on the in vitro efficacy of tamoxifen was shown [11, 12]. This evidence concerns the gene ESR1 and neoplasm.